<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0001915'>Aplastic anemia</z:hpo> (AA), <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>), and <z:hpo ids='HP_0004818'>paroxysmal nocturnal hemoglobinuria</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e>) are <z:e sem="disease" ids="C0678236" disease_type="Disease or Syndrome" abbrv="">rare disorders</z:e> of <z:hpo ids='HP_0005528'>bone marrow failure</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Once considered distinct entities, these three diseases are now believed to have overlapping pathophysiologies </plain></SENT>
<SENT sid="2" pm="."><plain>The <z:hpo ids='HP_0001915'>Aplastic Anemia</z:hpo> and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> International Foundation, a nonprofit organization that supports patients and families living with <z:hpo ids='HP_0005528'>bone marrow failure</z:hpo> disorders, sponsored a scientific symposium in Bethesda, MD, in March 2012 </plain></SENT>
<SENT sid="3" pm="."><plain>This report summarizes the symposium presentations by 30 of the world's leading AA, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>, and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e> researchers on recent findings, current areas of controversy, and recommendations for basic and clinical research to advance the field </plain></SENT>
</text></document>